Expression of tumour-specific antigens underlies cancer immunoediting
Cancer immunoediting is a process by which immune cells, particularly lymphocytes of the adaptive immune system, protect the host from the development of cancer and alter tumour progression by driving the outgrowth of tumour cells with decreased sensitivity to immune attack1, 2. Carcinogen-induced m...
Main Authors: | DuPage, Michel J., Mazumdar, Claire, Schmidt, Leah Marie, Cheung, Ann, Jacks, Tyler E. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2012
|
Online Access: | http://hdl.handle.net/1721.1/73483 https://orcid.org/0000-0001-5785-8911 https://orcid.org/0000-0001-9076-8475 |
Similar Items
-
Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
by: DuPage, Michel J., et al.
Published: (2014) -
MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020) -
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
by: DuPage, Michel J., et al.
Published: (2016) -
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
by: DuPage, Michel J., et al.
Published: (2014) -
Investigation of T cell-mediated immune surveillance against tumor-specific antigens in genetically engineered mouse models of cancer
by: Du Page, Michel Justin Porter
Published: (2011)